Credence Research Logo

Home » Marknaden för bioläkemedel

Marknaden för bioläkemedel efter produkttyp (monoklonala antikroppar, rekombinanta proteiner, rekombinanta hormoner, vacciner, rekombinanta enzymer, cell- och genterapier, cytokiner, interferoner och interleukiner, tillväxtfaktorer, andra produkttyper); efter terapeutisk tillämpning (onkologi, inflammatoriska och infektionssjukdomar, autoimmuna sjukdomar, metabola sjukdomar, hormonella sjukdomar, kardiovaskulära sjukdomar, neurologiska sjukdomar, andra terapeutiska tillämpningar); efter läkemedelstyp (patentskyddade/varumärkesskyddade biologiska läkemedel, biosimilarer); efter region – tillväxt, andel, möjligheter och konkurrensanalys, 2025 – 2032

Report ID: 206230 | Report Format : Excel, PDF

Begär ett gratisprov

Begär gratis prov

We prioritize the confidentiality and security of your data. Our promise: your information remains private.

Ready to Transform Data into Decisions?

Begär din provrapport och börja din resa mot välgrundade beslut

Tillhandahåller den strategiska kompassen för branschledare.

cr-clients-logos
Vanliga frågor:
Vad är marknadsstorleken för biopharmaceuticals-marknaden år 2025 och prognosen för 2032?

Biopharmaceuticals-marknaden värderades till 457 158,2 miljoner USD år 2025. Marknaden förväntas nå 783 488,82 miljoner USD år 2032.

Vad är CAGR för biopharmaceuticals-marknaden under 2025–2032?

Marknaden förväntas växa med en CAGR på 8% från 2025 till 2032. Denna tillväxt återspeglar en ökad adoption inom specialterapiområden och en utvidgning av tillgången.

Vilket är det största segmentet efter produkttyp år 2025?

Monoklonala antikroppar är den största produktsegmentet. Monoklonala antikroppar stod för 35,4% av marknadsandelen år 2025.

Vilka är de viktigaste faktorerna som driver biopharmaceuticals-marknaden?

Nyckelfaktorer för tillväxt inkluderar en ökande börda av specialiserade sjukdomar, fortsatt innovation inom biologiska plattformar och en expanderande tillverkningskapacitet. Förbättrad tillgång och överkomliga priser genom biosimilarer stöder också en bredare adoption.

Vilka är de ledande företagen på biopharmaceuticals-marknaden?

Ledande företag inkluderar Pfizer Inc., AbbVie Inc., Merck & Co., Inc., F. Hoffmann-La Roche Ltd. och Novartis AG. Andra stora aktörer inkluderar Johnson & Johnson Services, Inc., Bristol-Myers Squibb Company och Sanofi.

Vilken region leder biopharmaceuticalsmarknaden 2025?

Nordamerika leder marknaden 2025. Nordamerika stod för 43,6% av den globala intäkten 2025.

About Author

Shweta Bisht

Shweta Bisht

Healthcare & Biotech Analyst

Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.

View Profile

Related Reports

Adalimumab Drugs Market

The Adalimumab Drugs Market is projected to grow from USD 14,947.5 million in 2025 to an estimated USD 21,229.73 million by 2032, with a compound annual growth rate (CAGR) of 5.1% from 2025 to 2032.

Acute Myeloid Leukemia Therapeutics Market

The Global Acute Myeloid Leukemia (AML) Therapeutics Market size was valued at USD 1,933.8 million in 2018 to USD 3,349.2 million in 2024 and is anticipated to reach USD 6,823.4 million by 2032, at a CAGR of 9.33% during the forecast period

Argatroban Market

The Argatroban Market is projected to grow from USD 684.95 Million in 2024 to an estimated USD 911.10 Million by 2032, with a CAGR of 4.87% from 2024 to 2032.

Blood Platelets Market

The global Blood Platelets Market size was estimated at USD 6154.6 million in 2025 and is expected to reach USD 8044.68 million by 2032, growing at a CAGR of 3.9% from 2025 to 2032.

Biguanides Market

The global Biguanides Market size was estimated at USD 18.64 million in 2025 and is expected to reach USD 23.88 million by 2032, growing at a CAGR of 3.6% from 2025 to 2032.

Alopecia Treatment (Hair Loss) Market

The Alopecia Treatment / Hair Loss Market is projected to grow from USD 3657.5 million in 2025 to an estimated USD 5257.27 million by 2032, with a compound annual growth rate (CAGR) of 5.3% from 2025 to 2032.

Alzheimer’s Diagnosis and Drugs Market

The Alzheimer’s Diagnosis and Drugs Market is projected to grow from USD 8,136.6 million in 2025 to an estimated USD 11,487.23 million by 2032, with a compound annual growth rate (CAGR) of 5.1% from 2025 to 2032.

America Cancer Immunotherapy Market

The America Cancer Immunotherapy Market is projected to grow from USD 76,247.5 million in 2025 to an estimated USD 135,492.3 million by 2032, with a compound annual growth rate (CAGR) of 8.6% from 2025 to 2032.

Brachytherapy Treatment Planning Systems Market

The global Brachytherapy Treatment Planning Systems Market size was estimated at USD 1903.75 million in 2025 and is expected to reach USD 2981.81 million by 2032, growing at a CAGR of 6.62% from 2025 to 2032.

Brugada Syndrome Market

The global Brugada Syndrome market size was estimated at USD 1367.02 million in 2025 and is expected to reach USD 2000.48 million by 2032, growing at a CAGR of 5.59% from 2025 to 2032.

Cutaneous Fibrosis Treatment Market

The Cutaneous Fibrosis Treatment market size was valued at USD 701 million in 2024 and is anticipated to reach USD 1,201.96 million by 2032, at a CAGR of 6.98% during the forecast period.

Marknad för behandling av polymyosit

Marknadsstorleken för behandling av polymyosit värderades till 1 100,00 miljoner USD år 2018 och nådde 1 290,04 miljoner USD år 2024. Den förväntas nå 1 952,34 miljoner USD år 2032, med en årlig tillväxttakt (CAGR) på 5,39 % under prognosperioden.

Licensalternativ

The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing. Use restricted to one purchaser only.
$4999

To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis. Unlimited users allowed within one corporate location (e.g., regional office).
$5999

The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc. research team. Permitted for unlimited global use by all users within the purchasing corporation, such as all employees of a single company.
$7999

Report delivery within 24 to 48 hours

Snabbkontakt

Europe

+44 7453 598 606

North America

+1 6282 627 656

Email

[email protected]

Begär ett gratisprov

Smallform of Sample request

What people say?

User Review

Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.

Materialforskare
(privacy requested)

User Review

The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.

Imre Hof
Ledningsassistent, Bekaert

Betrodd av

cr-clients-logos

Request Sample